ArticleOPEN ACCESS

Promising therapy for neuroendocrine prostate cancer: current status and future directions

Therapeutic Advances in Medical Oncology
DOI: 10.1177/17588359241269676
11Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This review summarizes potential novel targets and therapies for NEPC treatment, including epigenetic regulators (EZH2 inhibitors, LSD-1 inhibitors), AURKA inhibitors, PARP inhibitors, and DLL3 targeted therapies, and combination of immunotherapies, etc. These novel targets and therapies may provide new opportunities in the treatment of NEPC.

Author supplied keywords

Cite

CITATION STYLE

APA

Fei, X., Xue, J. W., Wu, J. Z., Yang, C. Y., Wang, K. J., & Ma, Q. (2024, January 1). Promising therapy for neuroendocrine prostate cancer: current status and future directions. Therapeutic Advances in Medical Oncology. SAGE Publications Inc. https://doi.org/10.1177/17588359241269676

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free